Tandem Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$959K Sell
1,043
-144
-12% -$146K 0.43% 24
2025
Q4
$1.28M Buy
1,187
+120
+11% +$115K 0.57% 19
2025
Q3
$814K Buy
1,067
+115
+12% +$85.6K 0.39% 23
2025
Q2
$742K Sell
952
-32
-3% -$24.9K 0.37% 25
2025
Q1
$813K Buy
984
+284
+41% +$236K 0.43% 21
2024
Q4
$540K Buy
700
+47
+7% +$38.9K 0.28% 27
2024
Q3
$579K Sell
653
-40
-6% -$36K 0.29% 24
2024
Q2
$627K Sell
693
-5
-0.7% -$4K 0.34% 22
2024
Q1
$543K Sell
698
-98
-12% -$69.7K 0.3% 22
2023
Q4
$464K Sell
796
-38
-5% -$22.2K 0.27% 22
2023
Q3
$448K Sell
834
-2
-0.2% -$1.03K 0.27% 22
2023
Q2
$392K Sell
836
-349
-29% -$146K 0.24% 25
2023
Q1
$407K Sell
1,185
-38
-3% -$12.8K 0.25% 25
2022
Q4
$447K Buy
+1,223
New +$434K 0.28% 25

Other funds holding LLY

Tandem Wealth Advisors's LLY Position: Q1 2026 in Review

Tandem Wealth Advisors reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $146K and leaving 1,043 shares worth $959K. The position accounts for 0.43% of the portfolio, ranked #24.

Tandem Wealth Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.28M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Tandem Wealth Advisors held 1,043 shares of Eli Lilly worth $959K as of Q1 2026.
  • Tandem Wealth Advisors sold 144 Eli Lilly shares in Q1 2026, an estimated $146K.
  • Eli Lilly made up 0.43% of Tandem Wealth Advisors's portfolio in Q1 2026, its #24 holding.
  • Tandem Wealth Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Tandem Wealth Advisors's Eli Lilly position peaked at $1.28M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tandem Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.